July has been a fairly exciting month for those fe
Post# of 15624
OWC received approval from the Israeli Medical Cannabis Agency to perform an efficacy study using OWC's topical ointment on psoriatic patients.
The anxiously awaited Phase 1 tablet study was completed although there has been no official communication from the Company to Shareholders.
The share price of OWC's common stock trades at or near 52 week lows.